OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to ...

Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of ...

Tozaro has announced the appointment of Dr Jason Slingsb y as Chief Executive Officer. Jason will lead the company’s ...

When it comes to evolution, there is a need to be proactive, envisage the kind of evolution required and go after it very ...

Oxford Biomedica said in an update on Wednesday that it remains on track to meet its full-year guidance as outlined in its ...

The Motley Fool. DATE Wednesday, June 4, 2025 at 5 p.m. ET Read More: Earn up to $845 cash back this year just by changing ...

Udupi: In a decisive move to curb the spread of vector-borne diseases such as dengue and chikungunya, the Karnataka government has introduced strict enforcement measures targeting mosquito breeding ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

The company highlights the evolution of its aircraft design, momentum in its testing program and the continued development of ...

It’s no secret, and hasn’t been for some time, that identity is the preferred attack vector for cyber criminals and ...

The US Army experimented with an autonomous boat to support wet gap crossing operations during the Maneuver Support & ...

Technology experts say telecommunications networks are increasingly susceptible to security threats and that companies should ...